SCHEMBL12255366

SCHEMBL12255366

COC(=O)c1ccc(-c2cc(C)cc(C(F)(F)F)c2)c(Br)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.56
PDK2 Q15119 3/20 0.41
TLR2 O60603 1/20 0.41
TLR1 Q15399 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.40
CNR2 P34972 3/20 0.40
CNR1 P21554 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
LMNA P02545 2/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MTOR P42345 1/20 0.38
SYK P43405 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2387047 0.92 NOTUM (0.61) NOTUMPDK2TLR2TLR1GPBAR1
SCHEMBL12255631 0.86 RXRA (0.50) AKR1C3AKR1C2MTORSYKRXRA
SCHEMBL12255368 0.85 NOTUM (0.44) NOTUMPDK2TLR2TLR1GPBAR1
SCHEMBL12255362 0.85 KDM4E (0.47) NOTUMPDK2TLR2TLR1GPBAR1
SCHEMBL12255430 0.81 RXRA (0.54) NOTUMCNR2TDP1LMNARXRA
SCHEMBL12255795 0.79 GPBAR1 (0.43) NOTUMTLR2TLR1GPBAR1LMNA
SCHEMBL23226530 0.79 NOTUM (0.54) NOTUMTLR2TLR1AKR1C3AKR1C2
SCHEMBL13528365 0.78 NOTUM (0.47) NOTUMCNR2TDP1LMNAHSD17B10
SCHEMBL9907389 0.77 SYK (0.43) NOTUMTLR2TLR1GPBAR1LMNA
SCHEMBL2484166 0.76 KDM4E (0.51) NOTUMPDK2TLR2TLR1GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367679-B2 Biaryl carboxamides MERCK SHARP & DOHME CORP. (US) 2013-02-05 US disclosed
US-20110230498-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230498-A1 BIARYL CARBOXAMIDES PAFAH1B3, PAFAH1B2, FAAH2 NOTUM 486/4885PDK2 2916/4885TLR2 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.